Armed Forces Institute of Medical Sciences
  Home
  U.S. Component
      Commander
    Research Departments
      Enteric Diseases
      Entomology
      Immunology
      Retrovirology
      Virology
      Veterinary Medicine
    Support Departments
      Administration
      Logistics
      Emerging Diseases
    (GEIS)
  Thai Component
      Division of Research
      Division of Analysis
 
    Useful Information
      Library
      Contact Info
      Map & Directions
      New Comer/Visitor
      Employment
      Post Doc Opportunities
      Grants Assistance
      Check E-Mail
      Links
 
 

               Page 26

              

Diarrheal diseases

          Although not usually life-threatening, diarrheal and more severe clinical variants of dysentery can compromise a military mission because of their potential for rapid transmission. AFRIMS has been a world leader in developing rapid and accurate diagnostic techniques for the etiological agents of diarrheal disease. Remarkable success has been achieved in recognizing diarrheagenic E. coli strains and in the identification of non-culturable enteric pathogens using DNA probes and PCR technology. Primers have been identified for the major targets and work focuses on inhibitor removal for PCR sample preparation. New causes of diarrhea have been identified by AFRIMS scientists working throughout Asia. Recently, a new agent of chronic diarrhea, Cyclospora, was identified at the field site in Nepal. Additionally, there are studies underway to track the widespread emergence of multiple antibiotic resistance in a number of different etiologic agents. A new attenuated Shigella vaccine is being tested for safety and community spread at the International Centre for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B).

 

 

Collecting clinical data and stool specimens from children with diarrhea, Children’s Hospital, Bangkok, Thailand.

 

DISEASE

CURRENT PROJECTS
ETEC (Enterotoxogenic E. coli)                      Vibrio cholerae 0139 Risk assessment/epidemiological studies    Development of diagnostic tests
Shigella spp. Phase I test for safety of live attenuated Shigella flexneri vaccine in Bangladesh                    Diagnostic PCR
Campylobacter spp. Establishment of a field site for vaccine testing Development of diagnostic PCR
Cyclospora Development of diagnostic tests         Epidemiology of pathogen
Norwalk virus Risk assessment and epidemiology

Back to About AFRIMS

AFRIMS Home | Privacy Notice | Disclaimer | Contact Us